Skip to main content

Table 1 Patient characteristics

From: Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill

Parameter

No recurrence of AF

(n = 86)

Recurrence of AF

(n = 91)

Total

(n = 177)

P

Age (years)

65 (57–75)

71 (61–76)

69 (60–75)

0.10

Male

53 (61)

60 (66)

113 (64)

0.64

APACHE II

21 (17–26)

23 (17–29)

22 (17–28)

0.28

SAPS II

39 (30–49)

44 (31–58)

41 (31–53)

0.12

ICU LOS (days)

6 (3–12)

8 (4–16)

7 (4–13)

0.05

Hospital LOS (days)

21 (12–46)

31 (18–70)

25 (13–58)

0.09

ICU Outcome

   

0.83

 Died

10 (12)

13 (14)

23 (13)

 

 Discharged

75 (87)

77 (85)

152 (86)

 

 Transferred

1 (1)

1 (1)

2 (1)

 

Hospital Outcome

   

0.08

 Died

22 (26)

25 (27)

47 (27)

 

 Discharged Home

44 (51)

37 (41)

81 (46)

 

 Transferred

17 (20)

29 (32)

46 (26)

 

 Not recorded

3 (3)

0 (0)

3 (2)

 

Weight (kg)

80 (69–100)

(n = 79)

75 (65–90)

(n = 87)

78 (66–95)

(n = 166)

0.15

Height (cm)

170

(165–175)

(n = 76)

170

(162–175)

(n = 84)

170

(162–175)

(n = 160)

0.73

Body Mass Index

28 (25–34)

(n = 76)

26 (24–31)

(n = 84)

28 (24–33)

(n = 160)

0.06

Charlson Score

2 (1–4)

3 (2–5)

2 (1–4)

0.01

Concurrent use of digoxin*

9 (10)

25 (27)

34 (19)

0.004

Concurrent use of beta-blockers

46 (53)

42 (46)

88 (50)

0.37

  1. * All patients receiving digoxin were also on a beta-blocker
  2. Values are shown as median (IQR) or number (%) as appropriate
  3. AF Atrial fibrillation, APACHE Acute Physiology and Chronic Health Evaluation, BMI body mass index, ICU intensive care unit, LOS length of stay, SAPS Simplified Acute Physiology Score